These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32028407)

  • 1. AA amyloidosis associated with Castleman disease: A case report and review of the literature.
    Bernabei L; Waxman A; Caponetti G; Fajgenbaum DC; Weiss BM
    Medicine (Baltimore); 2020 Feb; 99(6):e18978. PubMed ID: 32028407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Clinical Improvement of Multicentric Castleman Disease (MCD) with Renal Involvement Following Treatment with Tocilizumab: AA Amyloidosis as a Possible Renal Involvement of MCD.
    Temmoku J; Sasajima T; Kuroda T; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Fujita Y; Matsuoka N; Asano T; Sato S; Yamada T; Hashimoto Y; Migita K
    Tohoku J Exp Med; 2023 Mar; 259(4):285-291. PubMed ID: 36653160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
    Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
    Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.
    Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
    Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.
    Ikeda S; Chisuwa H; Kawasaki S; Ozawa J; Hoshii Y; Yokota T; Aoi T
    J Clin Pathol; 1997 Nov; 50(11):965-7. PubMed ID: 9462253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease.
    Imamura K; Kojima S; Imamura T; Tsujita K
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35981748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CARE-compliant article: Unicentric Castleman disease presenting as a retroperitoneal mass of the upper edge of the pancreas: A case report.
    Zhou YX; Ji Y; Wu S
    Medicine (Baltimore); 2020 Mar; 99(11):e19515. PubMed ID: 32176100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidosis secondary to intrapulmonary Castleman disease mimicking pulmonary hyalinizing granuloma-like clinical features: A rare case report.
    Wang ST; Wang QP; Li J; Zhang T; Zhang L; Mao YY
    Medicine (Baltimore); 2019 Apr; 98(14):e15039. PubMed ID: 30946344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
    Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
    PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report.
    De Vito C; Papathomas G T; Pedica F; Kane P; Amir A; Heaton N; Quaglia A
    Ann Hepatol; 2019; 18(1):263-268. PubMed ID: 31113603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease.
    Lachmann HJ; Gilbertson JA; Gillmore JD; Hawkins PN; Pepys MB
    QJM; 2002 Apr; 95(4):211-8. PubMed ID: 11937647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unicentric Castleman disease: A case report of an atypical presentation and successful management.
    Muhammad T; Alkheder A; Mazloum A; Almooay A; Naziha L; Shaheen M
    Int J Surg Case Rep; 2024 May; 118():109688. PubMed ID: 38669805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine therapy in amyloidosis related with plasmacytic Castleman disease presenting with nephrotic syndrome.
    Paydas S; Paydas S; Ergin M
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):992-5. PubMed ID: 26354576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature.
    Cheng JL; Cui J; Wang Y; Xu ZZ; Liu F; Liang SB; Tian H
    World J Gastroenterol; 2018 Sep; 24(34):3958-3964. PubMed ID: 30228787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A 21-year-old male patient with nephrotic syndrome and "idiopathic" AA amyloidosis].
    Saura IM; Carretón A; López Guillén E; Alegría MS; Jimeno García L; Ferri B
    Nefrologia; 2004; 24 Suppl 3():109-12. PubMed ID: 15219083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report].
    Liu D; Chen J; Gao M; Yu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Oct; 56(5):928-931. PubMed ID: 39397477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castleman disease with renal amyloidosis: imaging findings and clinical significance.
    Moon WK; Kim SH; Im JG; Yeon KM; Han MC
    Abdom Imaging; 1995; 20(4):376-8. PubMed ID: 7549748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease.
    Perfetti V; Bellotti V; Maggi A; Arbustini E; De Benedetti F; Paulli M; Marinone MG; Merlini G
    Am J Hematol; 1994 Jul; 46(3):189-93. PubMed ID: 7910717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
    van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
    Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.
    Borocco C; Ballot-Schmit C; Ackermann O; Aladjidi N; Delaleu J; Giacobbi-Milet V; Jannier S; Jeziorski E; Maurier F; Perel Y; Piguet C; Oksenhendler E; Koné-Paut I; Galeotti C
    Orphanet J Rare Dis; 2020 Apr; 15(1):95. PubMed ID: 32303241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.